CCO Oncology Podcast

185 Épisodes

1. Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations

   Publié: 10/01/2022
2. Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

   Publié: 10/01/2022
3. An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

   Publié: 10/01/2022
4. Managing Lower-Risk Myelodysplastic Syndrome: Nursing Implications

   Publié: 22/12/2021
5. Managing Higher-Risk and Relapsed/Refractory Myelodysplastic Syndromes: Nursing Implications

   Publié: 22/12/2021
6. Key Factors Influencing Later-Line Treatment Selection for Patients With Metastatic Colorectal Cancer

   Publié: 17/12/2021
7. The Evolving Role of TKIs in First-line Treatment of Advanced HCC

   Publié: 14/12/2021
8. Expert Insight on Important Clinical Trial Data From ESGO 2021 Informing Treatment for Ovarian Cancer and Endometrial Cancers

   Publié: 23/11/2021
9. Experts Answer FAQs on Immunotherapy for Non-Small-Cell Lung Cancer

   Publié: 23/11/2021
10. Overcoming Acquired Resistance With Second-Generation TRK Inhibitors

    Publié: 09/11/2021
11. Role of TKIs in Nonadipocytic Soft Tissue Sarcoma and Advanced Osteosarcoma

    Publié: 02/11/2021
12. PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

    Publié: 26/10/2021
13. Optimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Publié: 21/10/2021
14. First-Generation TRK Inhibitors: Clinical Evidence and Indications

    Publié: 15/10/2021
15. PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

    Publié: 14/10/2021
16. Counseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A

    Publié: 08/10/2021
17. Rationale for NTRK Testing in Patients With Cancer

    Publié: 08/10/2021
18. Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer

    Publié: 07/10/2021
19. Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer

    Publié: 29/09/2021
20. Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma

    Publié: 28/09/2021